Short answer
iRhythm Holdings, Inc. (IRTC) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $199M (up 25.7% year over year) with net income of −$14M.
Q1 2026 key financials · XBRL
- Revenue
- $199M
- +25.7% YoY
- Net income
- −$14M
- +54.6% YoY
- Operating margin
- -8.1%
- Gross margin
- 70.9%
- EPS (diluted)
- −$0.43
- +55.7% YoY
Source: XBRL data from the iRhythm Holdings, Inc. (IRTC) Q1 2026 10-Q on SEC EDGAR. USD.
iRhythm Holdings, Inc. Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- New regulatory trigger: September 2025 proposed LCDs could restrict Medicare coverage for temporary nontherapeutic ambulatory cardiac monitoring
- Medicare exposure: CMS reimbursement represented approximately 26% of revenue for the three months ended March 31, 2026
- Updated compliance risk: FDA Product Code QYX may challenge Zio AT eligibility for mobile cardiac telemetry billing
- Competitive risk: Apple, Fitbit, and Samsung expanding ECG and irregular-heartbeat detection capabilities
- Financial risk: Commercial payor contracts permit termination with prior written notice
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other iRhythm Holdings, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.